DeepMed Research

PBLTT52CAR19

Generic Name: PBLTT52CAR19

Clinical Trials

TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)

Phase 1

Completed

Conditions: B Acute Lymphoblastic Leukemia

Interventions: Drug: PBLTT52CAR19

First Posted Date: 2020-09-21

Last Posted Date: 2024-03-07

Lead Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust

Target Recruit Count: 9

Registration Number: NCT04557436

Locations: 🇬🇧
Great Ormond Street Hospital, London, United Kingdom

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy